Chris Thompson | Head of Reseach | Ubika Research | Chris@UbikaResearch.com | 1 (416) 574-0469
Patrick Smith | Analyst | Ubika Research | Patrick@UbikaResearch.com | 1 (647) 444-5506
Richard Waxman | Associate | Ubika Research | Richard@UbikaResearch.com | 1 (647) 770-2185
The Ubika Marijuana Stock Index soared 143% year-over-year, outperforming the Canadian cannabis sector as a whole
Ubika Marijuana 20 Index (March 19 - May 17)
UMJ20: -15.1% (142.9% Y/Y)
TSX-V: -5.6% (-3.3% Y/Y)
HMMJ: -10.4% (81.3% Y/Y)
Dollar amounts in CAD unless otherwise stated.
Top Volume Gainers (m/m)
Cannabis Sector Spotlight
The Ubika Marijuana Index continues to outperform on a year-over-year basis, sprouting 143% higher since this time last year. Comparatively, the Horizons
Marijuana Life Sciences Index (HMMJ) climbed 81% while the TSXV declined 3% YoY.
This report examines a growing Canadian marijuana company that has caught our attention with its vertically-integrated business model. Sunniva Inc. (CSE:SNN, OTCQX:SNNVF), a cannabis developer of medical marijuana with operations in British Colombia and California, has underperformed its benchmark, the HMMJ, (11% decline vs 8% decline) since it began trading in January 2018. The full report can be found below.